Holen Sie sich die Stockscreener-App
6.25
2.29%
0.14
Handel nachbörslich:
6.17
-0.08
-1.28%
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
This Insider Has Just Sold Shares In Ardelyx - simplywall.st
Ardelyx Inc Live Share Prices and Trades. ARDX.US Live Streaming Share Prices. - London South East
Ardelyx (ARDX) price target increased by 12.82% to 13.46 - MSN
Ardelyx chief patient officer sells $43,803 in shares By Investing.com - Investing.com Canada
Ardelyx chief patient officer sells $43,803 in shares - Investing.com
Tax-related Ardelyx (ARDX) insider sale covers RSU withholding needs - Stock Titan
Ardelyx (ARDX) CFO executes 1,455-share tax sell-to-cover after RSU vest - Stock Titan
Ardelyx (ARDX) officer’s RSU vesting triggers 2,306-share tax sell - Stock Titan
Ardelyx (ARDX) HR chief sells 1,846 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) Chief Commercial Officer sells 7,998 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) chief business officer logs 7,248-share tax sell-to-cover - Stock Titan
Ardelyx (ARDX) Chief Patient Officer sells 6,989 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) CEO Raab executes 54,748-share RSU tax sell-to-cover - Stock Titan
Ardelyx president & CEO Michael Raab sells $261,612 of ARDX stock - Investing.com India
What Triggered Ardelyx's Post-Earnings Plunge - Kavout
Ardelyx Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
ARDX (NASDAQ: ARDX) files Form 144 for 24,986 RSUs vesting - Stock Titan
ARDX (NASDAQ: ARDX) reports 5,355 RSUs vest; insider sales noted - Stock Titan
James Parker Brady files Form 144 for 6,216 ARDX shares (ARDX) - Stock Titan
Proposed Common Stock Sale by ARDX Affiliate (NASDAQ: ARDX) - Stock Titan
ARDX (NASDAQ) insider reports 10,388 RSUs vesting; prior sales 4,991 shares - Stock Titan
Michael Raab reports multiple ARDX share sales (ARDX) and RSU vesting - Stock Titan
ARDX (NASDAQ: ARDX) files Form 144 for 7,771 vested RSUs and lists recent insider sales - Stock Titan
Ardelyx Insider Sold Shares Worth $261,612, According to a Recent SEC Filing - Moomoo
Insider sale reported for ARDX (ARDX): 24,041 RSU shares vest - Stock Titan
Ardelyx (ARDX) CEO sells 41,666 shares in 10b5-1 trade, exercises options - Stock Titan
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 - The Manila Times
A Look At Ardelyx (ARDX) Valuation After New Long Term XPHOZAH Data Strengthens Safety And Efficacy Profile - simplywall.st
Ardelyx, Inc.Common Stock (NQ: ARDX - The Chronicle-Journal
Ardelyx (ARDX) Is Down 8.1% After New Long-Term XPHOZAH Dialysis DataHas The Bull Case Changed? - simplywall.st
Janus Henderson (ARDX) discloses 8.37M‑share, 3.4% position in Ardelyx - Stock Titan
ARDX Stock Chart | ARDELYX INC (NASDAQ:ARDX) - ChartMill
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
Ardelyx, Inc. $ARDX Stock Position Increased by Vanguard Group Inc. - MarketBeat
State Street (ARDX) reports 13.6M-share | 5.5% stake via advisory entities - Stock Titan
TradingKey - TradingKey
Assessing Ardelyx (ARDX) Valuation After New Long Term XPHOZAH Safety Data Presentation - simplywall.st
Ardelyx (ARDX) Is Up 10.3% After Long-Term XPHOZAH Safety Data In Dialysis PatientsWhat's Changed - Yahoo Finance
Why Ardelyx (ARDX) Is Up 10.3% After New Long-Term XPHOZAH Dialysis Data And What's Next - simplywall.st
Ardelyx: Low Price, But High Implied Valuation (NASDAQ:ARDX) - Seeking Alpha
Ardelyx, Inc. (ARDX) Investor Outlook: Analyzing The 134% Potential Upside - DirectorsTalk Interviews
Ardelyx presents long-term safety data for XPHOZAH at NKF meeting By Investing.com - Investing.com South Africa
Assessing Ardelyx (ARDX) Valuation After Q1 2026 Results And Reaffirmed Revenue Guidance - Yahoo Finance
Ardelyx presents long-term safety data for XPHOZAH at NKF meeting - Investing.com
Dialysis drug cut phosphate without shifting other electrolytes in trials - Stock Titan
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - TMX Newsfile
Ardelyx (ARDX) Q1 2026 Earnings Transcript - AOL.com
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Ardelyx (NASDAQ:ARDX) Strengthens Amid Biotech Momentum - Kalkine Media
Ardelyx, Inc. (NASDAQ:ARDX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Moomoo
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
Ardelyx reiterates 2026 guidance as IBSRELA targets $1B in 2029 while advancing ACCEL CIC Phase III enrollment by year-end - MSN
A Look At Ardelyx (ARDX) Valuation After Strong Q1 Results And Updated 2026 Guidance - simplywall.st
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):